Which has better earnings & valuation, PHR or SDGR?

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.30 $2.31M $0.17 59.19 Schrodinger $255.87M 8.37 -$103.26M -$0.74 N/A

Is PHR or SDGR more profitable?

Phreesia has a net margin of 2.06% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.22% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 2.06% 5.22% 3.02% Schrodinger -20.98% -16.37% -8.19%

Does the media refer more to PHR or SDGR?

In the previous week, Schrodinger had 6 more articles in the media than Phreesia. MarketBeat recorded 12 mentions for Schrodinger and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat Schrodinger's score of 0.64 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, GDRX or PHR?

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.45 $30.44M $0.04 84.50 Phreesia $480.59M 1.30 $2.31M $0.17 59.19

Is GDRX or PHR more profitable?

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 2.06%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% Phreesia 2.06% 5.22% 3.02%

Which has better valuation and earnings, CERT or PHR?

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Phreesia $480.59M 1.30 $2.31M $0.17 59.19

Is CERT or PHR more profitable?

Phreesia has a net margin of 2.06% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.22% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Phreesia 2.06% 5.22% 3.02%

Does the media favor CERT or PHR?

In the previous week, Phreesia had 5 more articles in the media than Certara. MarketBeat recorded 6 mentions for Phreesia and 1 mentions for Certara. Phreesia's average media sentiment score of 0.73 beat Certara's score of -0.40 indicating that Phreesia is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Phreesia 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PHR or TDOC?

In the previous week, Teladoc Health had 6 more articles in the media than Phreesia. MarketBeat recorded 12 mentions for Teladoc Health and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat Teladoc Health's score of 0.47 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teladoc Health 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, PHR or HSTM?

HealthStream has lower revenue, but higher earnings than Phreesia. HealthStream is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.30 $2.31M $0.17 59.19 HealthStream $304.06M 2.81 $18.34M $0.72 40.60

Does the media favor PHR or HSTM?

In the previous week, HealthStream had 7 more articles in the media than Phreesia. MarketBeat recorded 13 mentions for HealthStream and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat HealthStream's score of 0.40 indicating that Phreesia is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phreesia 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthStream 3 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Phreesia (PHR) Competitors

$10.06 -0.22 (-2.12%)

Closing price 09/18/2026 03:59 PM Eastern

Extended Trading

$10.07 +0.01 (+0.13%)

As of 09/18/2026 07:30 PM Eastern

Compare

PHR vs. SDGR, GDRX, CERT, TDOC, and HSTM

Should you buy Phreesia stock or one of its competitors? Phreesia's main competitors and comparable companies include Schrodinger (SDGR), GoodRx (GDRX), Certara (CERT), Teladoc Health (TDOC), and HealthStream (HSTM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Phreesia compare to Schrodinger?

Phreesia (NYSE:PHR) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

Phreesia has a net margin of 2.06% compared to Schrodinger's net margin of -20.98%. Phreesia's return on equity of 5.22% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	2.06%	5.22%	3.02%
Schrodinger	-20.98%	-16.37%	-8.19%

Phreesia has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.30	$2.31M	$0.17	59.19
Schrodinger	$255.87M	8.37	-$103.26M	-$0.74	N/A

Phreesia has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market.

92.1% of Phreesia shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 5.2% of Phreesia shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Phreesia currently has a consensus target price of $14.00, suggesting a potential upside of 39.14%. Schrodinger has a consensus target price of $20.50, suggesting a potential downside of 29.36%. Given Phreesia's stronger consensus rating and higher probable upside, research analysts clearly believe Phreesia is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

In the previous week, Schrodinger had 6 more articles in the media than Phreesia. MarketBeat recorded 12 mentions for Schrodinger and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat Schrodinger's score of 0.64 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Phreesia beats Schrodinger on 12 of the 16 factors compared between the two stocks.

How does Phreesia compare to GoodRx?

GoodRx (NASDAQ:GDRX) and Phreesia (NYSE:PHR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

GoodRx has a net margin of 2.07% compared to Phreesia's net margin of 2.06%. GoodRx's return on equity of 7.22% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
Phreesia	2.06%	5.22%	3.02%

GoodRx has a beta of 1.59, suggesting that its stock price is 59% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 92.1% of Phreesia shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 5.2% of Phreesia shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

GoodRx presently has a consensus price target of $4.23, indicating a potential upside of 25.07%. Phreesia has a consensus price target of $14.00, indicating a potential upside of 39.14%. Given Phreesia's stronger consensus rating and higher probable upside, analysts plainly believe Phreesia is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37

GoodRx has higher revenue and earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.45	$30.44M	$0.04	84.50
Phreesia	$480.59M	1.30	$2.31M	$0.17	59.19

In the previous week, Phreesia had 6 more articles in the media than GoodRx. MarketBeat recorded 6 mentions for Phreesia and 0 mentions for GoodRx. Phreesia's average media sentiment score of 0.73 beat GoodRx's score of 0.00 indicating that Phreesia is being referred to more favorably in the news media.

Company	Overall Sentiment
GoodRx	Neutral
Phreesia	Positive

Summary

GoodRx and Phreesia tied by winning 8 of the 16 factors compared between the two stocks.

How does Phreesia compare to Certara?

Certara (NASDAQ:CERT) and Phreesia (NYSE:PHR) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

74.0% of Certara shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 5.2% of Phreesia shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, Phreesia has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Phreesia has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Phreesia	$480.59M	1.30	$2.31M	$0.17	59.19

In the previous week, Phreesia had 5 more articles in the media than Certara. MarketBeat recorded 6 mentions for Phreesia and 1 mentions for Certara. Phreesia's average media sentiment score of 0.73 beat Certara's score of -0.40 indicating that Phreesia is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phreesia	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Phreesia has a net margin of 2.06% compared to Certara's net margin of -16.75%. Phreesia's return on equity of 5.22% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Phreesia	2.06%	5.22%	3.02%

Certara currently has a consensus price target of $8.28, indicating a potential downside of 1.69%. Phreesia has a consensus price target of $14.00, indicating a potential upside of 39.14%. Given Phreesia's higher probable upside, analysts plainly believe Phreesia is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37

Summary

Phreesia beats Certara on 13 of the 17 factors compared between the two stocks.

How does Phreesia compare to Teladoc Health?

Phreesia (NYSE:PHR) and Teladoc Health (NYSE:TDOC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Teladoc Health had 6 more articles in the media than Phreesia. MarketBeat recorded 12 mentions for Teladoc Health and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat Teladoc Health's score of 0.47 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teladoc Health	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Phreesia has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.12, indicating that its share price is 112% more volatile than the broader market.

Phreesia has a net margin of 2.06% compared to Teladoc Health's net margin of -7.13%. Phreesia's return on equity of 5.22% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	2.06%	5.22%	3.02%
Teladoc Health	-7.13%	-12.15%	-5.83%

Phreesia has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.30	$2.31M	$0.17	59.19
Teladoc Health	$2.53B	0.45	-$200.32M	-$0.99	N/A

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 0.7% of Teladoc Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Phreesia currently has a consensus target price of $14.00, indicating a potential upside of 39.14%. Teladoc Health has a consensus target price of $7.54, indicating a potential upside of 19.31%. Given Phreesia's stronger consensus rating and higher possible upside, equities analysts plainly believe Phreesia is more favorable than Teladoc Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Phreesia beats Teladoc Health on 13 of the 16 factors compared between the two stocks.

How does Phreesia compare to HealthStream?

Phreesia (NYSE:PHR) and HealthStream (NASDAQ:HSTM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

HealthStream has lower revenue, but higher earnings than Phreesia. HealthStream is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.30	$2.31M	$0.17	59.19
HealthStream	$304.06M	2.81	$18.34M	$0.72	40.60

Phreesia presently has a consensus target price of $14.00, indicating a potential upside of 39.14%. HealthStream has a consensus target price of $27.00, indicating a potential downside of 7.63%. Given Phreesia's stronger consensus rating and higher probable upside, analysts clearly believe Phreesia is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	10 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.37
HealthStream	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, HealthStream had 7 more articles in the media than Phreesia. MarketBeat recorded 13 mentions for HealthStream and 6 mentions for Phreesia. Phreesia's average media sentiment score of 0.73 beat HealthStream's score of 0.40 indicating that Phreesia is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phreesia	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthStream	3 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Phreesia has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, HealthStream has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market.

92.1% of Phreesia shares are held by institutional investors. Comparatively, 69.6% of HealthStream shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Comparatively, 20.4% of HealthStream shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

HealthStream has a net margin of 6.60% compared to Phreesia's net margin of 2.06%. HealthStream's return on equity of 6.81% beat Phreesia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	2.06%	5.22%	3.02%
HealthStream	6.60%	6.81%	4.64%

Summary

Phreesia and HealthStream tied by winning 8 of the 16 factors compared between the two stocks.

Get Phreesia News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHR vs. The Competition

Export

Metric	Phreesia	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$623.19M	$1.72B	$7.24B	$23.10B
Dividend Yield	N/A	4.71%	2.57%	3.62%
P/E Ratio	59.19	20.07	275.49	28.21
Price / Sales	1.30	89.94	646.01	20.34
Price / Cash	13.45	31.60	76.25	36.36
Price / Book	1.68	6.14	10.46	4.67
Net Income	$2.31M	-$18.66M	$3.49B	$1.07B
7 Day Performance	-2.66%	1.79%	0.59%	-1.64%
1 Month Performance	-16.15%	1.77%	-1.74%	-3.60%
1 Year Performance	-57.85%	-14.53%	18.13%	8.41%

Phreesia Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHR Phreesia	4.43 of 5 stars	$10.06 -2.1%	$14.00 +39.1%	-57.8%	$623.19M	$480.59M	59.19	1,789	High Trading Volume
SDGR Schrodinger	0.9501 of 5 stars	$20.75 +9.1%	$20.50 -1.2%	+49.2%	$1.40B	$259.04M	N/A	850	News Coverage Options Volume Gap Down High Trading Volume
GDRX GoodRx	4.1478 of 5 stars	$3.56 +5.0%	$4.23 +18.7%	-18.2%	$1.16B	$785.23M	89.02	697	Positive News
CERT Certara	0.9784 of 5 stars	$8.00 +6.0%	$8.28 +3.5%	-26.7%	$1.15B	$421.75M	N/A	1,576	Positive News
TDOC Teladoc Health	2.6155 of 5 stars	$6.51 +5.6%	$7.54 +15.8%	-20.4%	$1.12B	$2.49B	N/A	5,600	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHR) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Phreesia (PHR) Competitors

PHR vs. SDGR, GDRX, CERT, TDOC, and HSTM

How does Phreesia compare to Schrodinger?

Summary

How does Phreesia compare to GoodRx?

Summary

How does Phreesia compare to Certara?

Summary

How does Phreesia compare to Teladoc Health?

Summary

How does Phreesia compare to HealthStream?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR vs. The Competition

Phreesia Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Phreesia (PHR) Competitors

PHR vs. SDGR, GDRX, CERT, TDOC, and HSTM

How does Phreesia compare to Schrodinger?

Is PHR or SDGR more profitable?

Which has better earnings & valuation, PHR or SDGR?

Which has more risk & volatility, PHR or SDGR?

Do institutionals & insiders hold more shares of PHR or SDGR?

Do analysts prefer PHR or SDGR?

Does the media refer more to PHR or SDGR?

Summary

How does Phreesia compare to GoodRx?

Is GDRX or PHR more profitable?

Which has more risk and volatility, GDRX or PHR?

Do institutionals and insiders have more ownership in GDRX or PHR?

Do analysts prefer GDRX or PHR?

Which has stronger valuation & earnings, GDRX or PHR?

Does the media favor GDRX or PHR?

Summary

How does Phreesia compare to Certara?

Do institutionals & insiders have more ownership in CERT or PHR?

Which has more volatility & risk, CERT or PHR?

Which has better valuation and earnings, CERT or PHR?

Does the media favor CERT or PHR?

Is CERT or PHR more profitable?

Do analysts rate CERT or PHR?

Summary

How does Phreesia compare to Teladoc Health?

Does the media prefer PHR or TDOC?

Which has more volatility and risk, PHR or TDOC?

Is PHR or TDOC more profitable?

Which has stronger earnings & valuation, PHR or TDOC?

Do institutionals and insiders believe in PHR or TDOC?

Do analysts recommend PHR or TDOC?

Summary

How does Phreesia compare to HealthStream?

Which has stronger valuation and earnings, PHR or HSTM?

Do analysts recommend PHR or HSTM?

Does the media favor PHR or HSTM?

Which has more risk and volatility, PHR or HSTM?

Do institutionals & insiders have more ownership in PHR or HSTM?

Is PHR or HSTM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHR vs. The Competition

Phreesia Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools